YHLO produced COVID-19 Rapid Test Authorized by Japanese PMDA
On February 10th, 2022, YHLO produced COVID-19 Rapid Antigen Test Kit was authorized by Japanese PMDA (Pharmaceuticals and Medical Devices Agency), which is supplied to YHLO’s Japanese marketing authorization holder, MBL (MEDICAL & BIOLOGICAL LABORATORIES CO., LTD.). With the Japanese PMDA certificate, the product will be available for sale in Japan, which can be used for professional use and self-testing.
Attachments:
Previous
MORE NEWS
China-Hospeq 2026: YHLO Brings Diagnostic Solutions to Global Health Partners
YHLO Brings Diagnostic Solutions to Global Health Partners at China-Hospeq 2026
2026-08-20
ADLM 2026: YHLO Brings Proven Lab Automation to the Americas
YHLO showcases its innovative products and academic achievements at ADLM 2026.
2026-08-01
Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
